Sensata Technologies Holding P - SIC # 3812 - SEARCH, DETECTION, NAVIGATION, GUIDANCE, AERONAUTICAL, AND NAUTIC

Ticker Exchange SIC # Website Latest Ticker
ST New York 3812 http://investors.sensata.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sensata Technologies Holding P

Sensata (ST) Q3 Earnings Preview: What to Look Out For - Oct 23rd, 2018 8:32 am
This Auto-Parts Maker Deserves Another Look — as a Tech Stock - Oct 23rd, 2018 4:00 am
Sensata Technologies to Feature New Product Suite Focusing on Enhanced Automation, Productivity and Safety at SPS IPC Drives 2018 - Oct 15th, 2018 2:10 am
Sensata Technologies Announces Date and Time of Third Quarter 2018 Earnings Release and Webcast - Oct 9th, 2018 5:30 am
Chip Stocks Face Tougher Quarter and Year: Stanley - Oct 4th, 2018 1:01 pm
Sensata Technologies Holding PLC (NYSE:ST): Time For A Financial Health Check - Sep 26th, 2018 12:53 pm
Sensata Technologies Strengthens Position in Electrification through Acquisition of GIGAVAC - Sep 24th, 2018 3:10 pm
Sensata Technologies Completes Divestment of Valves Business to Pacific Industrial Co. - Sep 4th, 2018 1:00 am
MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP - Aug 27th, 2018 9:02 am
ST vs. BMI: Which Stock Is the Better Value Option? - Jul 26th, 2018 7:30 am
Edited Transcript of ST.N earnings conference call or presentation 24-Jul-18 12:00pm GMT - Jul 25th, 2018 1:18 pm
Sensata: 2Q Earnings Snapshot - Jul 24th, 2018 4:13 am
Sensata Technologies Holding plc to Host Earnings Call - Jul 24th, 2018 4:00 am
Earnings Outlook For Sensata Technologies - Jul 23rd, 2018 2:02 pm
MPI: Orphan Drug designation on Oncology Venture's dovitinib for Adenoid Cystic Carcinoma - Jun 28th, 2018 5:16 am
MPI: First Patient dosed in Phase 2 Study of the PARP Inhibitor 2X-121 for Breast Cancer - Jun 26th, 2018 3:46 am
Does Sensata Technologies Holding PLC’s (NYSE:ST) PE Ratio Warrant A Sell? - Jun 23rd, 2018 7:51 am